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was included in the overall estimate of WTP. CONCLUSIONS:
The results from this study illustrate the value that OA patients
attribute to the reduction in GI-side effects associated with Cox-
2 selective inhibitors such as VIOXX. On average, patients were
willing to pay $A57.85 per month for a medication that specif-
ically reduced the risk of both complicated and uncomplicated
PUBs.
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OBJECTIVES: We describe pain level, medication use, potential
medication-related events, perceived medication effectiveness,
and medication switching among osteoarthritis (OA) patients.
METHODS: Patients totaling 4386 with self-reported OA com-
pleted an internet survey. Recent OA pain level was reported on
a 0–10 scale (10 = “worst possible” pain). Respondents reported
regular Rx and OTC medication use (~{!]~} 3x/wk), perceived
medication effectiveness, and frequency of 6 conditions possibly
associated with OA treatment(s) such as diarrhea, nausea/vom-
iting, heartburn, stomach pain, headache, and dizziness. Cate-
gorical frequencies were conservatively converted to continuous
variables (e.g., 1–3x a month = 1/month) to facilitate estimation.
Statistical comparisons were made using student’s t tests, X2, and
ANOVA. Logistic regression was used to identify predictors of
medication switching. RESULTS: Demographics: Mean age 55.3
years, 70.8% female, 91.4% white. Average recent OA pain was
4.9; 70.1% reported pain in 3 joints. 28.0%, 27.8%, and 32.2%
reported taking only OTC, only Rx, or both on a regular basis,
respectively. Twenty-ﬁve percent felt their OA medications were
slightly or not effective; 54.1% felt they were only moderately
effective. A total of 34.4% switched or discontinued medica-
tion(s) during the past year; 41.5% and 35.1% of these patients
cited lack of effectiveness and/or side-effects as a reason, respec-
tively. Respondents using both Rx and OTC OA medications
experienced potentially medication-related events more fre-
quently than those not taking medication. Patients who switched
OA medications reported experiencing higher recent OA pain,
GI events (compared to non-GI), pain in more than 6 joints, and
more than 3 events potentially related to medication use and
were more likely to be female (all p £ 0.05). CONCLUSIONS:
The burden of OA on patients in terms of pain, medication use,
and potential side effects is high. Only 1 in 4 patients in our
sample perceived their OA medications to be effective, and most
reported experiencing at least some OA pain despite regular
medication use.
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OBJECTIVES: We examined productivity hours lost due to pain,
site of pain, and number of joints affected among workers and
non-workers with osteoarthritis (OA). METHODS: A total of
4386 self-reported OA patients completed an internet survey.
Respondents reported previous week’s work or daily activity
hours lost due to OA, OA pain (scale 0–10, 10 = “worst possi-
ble” pain over past 24 hours), site(s) of pain, and affected
joint(s). Impact of pain, number of affected joints, and site of
pain on total hours lost was evaluated using generalized linear
regression and including a pain level-employment interaction.
RESULTS: Demographics: mean age 55.3 years, 70.8% female,
91.4% white. Average recent OA pain was 4.9. Average hours
lost were 10.2 (SD 24.1). Non-workers reported more hours 
lost (18.2 vs. 1.7; p < 0.0001) and higher pain (5.4 vs. 4.5, 
p < 0.0001) than workers. Higher pain was associated with
increased lost hours for both groups, but more so for non-
workers (p < 0.0001). Both workers and non-workers with pain
in >7 joints lost signiﬁcantly more hours than those with fewer
affected joints (3.5 vs. 1.4 for workers, 31.6 vs. 14.1 for non-
workers, p < 0.0001). Lost hours were signiﬁcantly greater for
lower vs. upper body pain for both groups (1.5 vs. 0.5 for
workers, 10.9 vs. 5.6 for non-workers, p < 0.0001). Higher pain,
pain in >7 joints, low back pain, and pain-employment interac-
tion predicted hours lost due to OA (all p £ 0.05) after control-
ling for age, race, gender, education, employment, income, and
regular medication use. Speciﬁc joint sites did not predict lost
hours. The pain and pain-employment interaction parameters
indicate that non-workers lose more hours than workers at every
pain level and this differential increases with higher pain. CON-
CLUSIONS: Recent OA pain and the number of affected joints
but not individual pain site(s) impacted productivity. These
effects were greater for non-workers who likely have more severe
OA symptoms.
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It is well recognized that African-American (AA) patients with
knee osteoarthritis (OA) undergo total knee replacement (TKR)
at lower rates than their White (W) counterparts, OA. OBJEC-
TIVE: The purpose of this study was to evaluate the preferences
and beliefs of patients with knee OA from diverse ethnic back-
grounds in relation to TKR. METHODS: One hundred ninety-
eight patients with knee OA attending a health institution
participated in a survey; 67 were W, 66 AA and 65 Hispanic (H);
63% were female; mean age was 64.2 years. Patients were asked
if their physicians had recommended TKR, whether they had
thought about having the procedure, about their perceptions on
the beneﬁts and risks of TKR, and their potential expectations
if they were to undergo the procedure. RESULTS: A physician
had recommended TKR to 27% of AA, 15% of W and 11% of
H (p = 0.04). However, more W had considered undergoing
TKR: 42% v 30% AA and 25% H (p = 0.10); 97% of W, 85%
of AA and 75% of H reported that they would consider TKR if
their OA worsened and the procedure were recommended by
their physician (p = 0.002). Statistical differences were observed
in the perception of efﬁcacy across the groups: W were more
likely to consider TKR as a beneﬁcial procedure, and as an inter-
vention that could be helpful for them, compared to AA and H;
88% of W, 70% of AA and 57% of H had a close friend or rel-
ative who had undergone TKR (p = 0.001); these patients were
more likely to consider TKR than those who did not have rela-
tives or friends with TKR (p = 0.001). CONCLUSIONS: Ethnic
minority patients with knee OA are less likely to consider TKR,
preferences are associated with differences in perception of
